Area of research
Surgery · Oncology
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Organ Transplantation Techniques and Outcomes, Hepatocellular Carcinoma Treatment and Prognosis, and Gastric Cancer Management and Outcomes.
Supplementary Figure 8 from Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity
Supplementary Figure 3 from Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity
Supplementary Figure 4 from Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity
Supplementary Figure 4 from Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity
Supplementary Figure 5 from Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity
Data from Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity
Supplementary Figure 6 from Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity
Supplementary Figure 1 from Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity
Supplementary Figure 3 from Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity
Supplementary Figure 2 from Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity
Data from Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity
Supplementary Figure 5 from Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity
Supplementary Figure 7 from Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity
Supplementary Figure 8 from Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity
Supplementary Figure 1 from Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity
Supplementary Figure 7 from Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity
Supplementary Figure 2 from Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity
Supplementary Figure 6 from Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity
Sphingosine-1-phosphate promotes tumor development and liver fibrosis in mouse model of congestive hepatopathy.
Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer.
Short- and long-term outcomes of laparoscopic versus open gastrectomy for locally advanced gastric cancer following neoadjuvant chemotherapy.
The Prognostic Significance of C-reactive Protein-To-Lymphocyte Ratio in Colorectal Liver Metastases.
Preoperative controlling nutritional status (CONUT) score predicts long-term outcomes in patients with non-B non-C hepatocellular carcinoma after curative hepatic resection.
Treatment of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma.
Single-blind randomized clinical trial of transinguinal preperitoneal repair using self-expanding mesh patch vs. Lichtenstein repair for adult male patients with primary unilateral inguinal hernia.
Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells.
Signification of Systemic Immune-Inflammation Index for prediction of prognosis after resecting in patients with colorectal cancer.
Impairment of DYRK2 by DNMT1‑mediated transcription augments carcinogenesis in human colorectal cancer.
Six autoantibodies as potential serum biomarkers of hepatocellular carcinoma: A prospective multicenter study.
Segment IV approach for difficult laparoscopic cholecystectomy.
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Surgery · Oncology →